000 01559 a2200409 4500
005 20250513194805.0
264 0 _c19991130
008 199911s 0 0 eng d
022 _a0007-1048
024 7 _a10.1046/j.1365-2141.1999.01442.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHellström-Lindberg, E
245 0 0 _aSpontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology. Scandinavian MDS Group, Sweden and Norway.
_h[electronic resource]
260 _bBritish journal of haematology
_cJun 1999
300 _a966-73 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aErythropoietin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFilgrastim
650 0 4 _aGranulocyte Colony-Stimulating Factor
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMyelodysplastic Syndromes
_xblood
650 0 4 _aPlatelet Count
650 0 4 _aRecombinant Proteins
650 0 4 _aThrombocytopenia
_xblood
650 0 4 _aThrombopoietin
_xblood
700 1 _aKanter-Lewensohn, L
700 1 _aNichol, J
700 1 _aOst, A
773 0 _tBritish journal of haematology
_gvol. 105
_gno. 4
_gp. 966-73
856 4 0 _uhttps://doi.org/10.1046/j.1365-2141.1999.01442.x
_zAvailable from publisher's website
999 _c10511385
_d10511385